AIMC Topic: Leukemia, Myeloid, Acute

Clear Filters Showing 61 to 70 of 83 articles

Consistent quantitative gene product expression: #2. Antigen intensities on bone marrow cells are invariant between individuals.

Cytometry. Part A : the journal of the International Society for Analytical Cytology
Five reference populations in bone marrow specimens were identified by flow cytometry using specific combinations of reagents in order define the variation of gene product expression intensities both within and between individuals. Mature lymphocytes...

Consistent quantitative gene product expression: #1. Automated identification of regenerating bone marrow cell populations using support vector machines.

Cytometry. Part A : the journal of the International Society for Analytical Cytology
Identification and quantification of maturing hematopoietic cell populations in flow cytometry data sets is a complex and sometimes irreproducible step in data analysis. Supervised machine learning algorithms present promise to automatically classify...

Integrating GO and KEGG terms to characterize and predict acute myeloid leukemia-related genes.

Hematology (Amsterdam, Netherlands)
BACKGROUND/OBJECTIVE: Acute myeloid leukemia (AML) is a progressive and malignant cancer of myelogenous blood cells, which disturbs the production of normal blood cells. Although several risk and genetic factors (AML-related genes) have been investig...

A machine learning framework for cross-institute standardized analysis of flow cytometry in differentiating acute myeloid leukemia from non-neoplastic conditions.

Computers in biology and medicine
Flow cytometry (FC) remains a cornerstone diagnostic tool for acute myeloid leukemia (AML), yet standardizing panels across laboratories presents persistent challenges. Our study introduces a validated machine learning framework enabling cross-panel ...

Blood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes.

Blood
Inflammation is increasingly recognized as a critical factor in acute myeloid leukemia (AML) pathogenesis. We performed blood-based proteomic profiling of 251 inflammatory proteins in 543 patients with newly diagnosed AML. Using a machine learning mo...

Integrative analysis of epigenetic subtypes in acute myeloid Leukemia: A multi-center study combining machine learning for prognostic and therapeutic insights.

PloS one
BACKGROUND: Acute Myeloid Leukemia (AML) exhibits significant heterogeneity in clinical outcomes, yet current prognostic stratification systems based on genetic alterations alone cannot fully capture this complexity. This study aimed to develop an in...

High-dimensional Immune Profiles and Machine Learning May Predict Acute Myeloid Leukemia Relapse Early following Transplant.

Journal of immunology (Baltimore, Md. : 1950)
Identification of early immune signatures associated with acute myeloid leukemia (AML) relapse following hematopoietic stem cell transplant (HSCT) is critical for patient outcomes. We analyzed PBMCs from 58 patients with AML undergoing HSCT, focusing...

Application of m6A regulators to predict transformation from myelodysplastic syndrome to acute myeloid leukemia via machine learning.

Medicine
Myelodysplastic syndrome (MDS) frequently transforms into acute myeloid leukemia (AML). Predicting the risk of its transformation will help to make the treatment plan. Levels of expression of N6-methyladenosine (m6A) regulators is difference in patie...

Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.

The Lancet. Digital health
BACKGROUND: Acute leukaemias are life-threatening haematological cancers characterised by the infiltration of transformed immature haematopoietic cells in the blood and bone marrow. Prompt and accurate diagnosis of the three main acute leukaemia subt...